Whitman and Nietzsche

This volume will be a great aid to students and scholars alike in American literature, American thought, the history of ideas, and comparative literature. Stavrou draws from the entire bodies of work by Whitman and Nietzsche to explore the parallels in the authors' conceptions of paradox, the totality of life, and solitude among other themes in this exploration of the underlying philosophical similarities of these two great writers of the nineteenth century

Whitman and Nietzsche

This volume will be a great aid to students and scholars alike in American literature, American thought, the history of ideas, and comparative literature. Stavrou draws from the entire bodies of work by Whitman and Nietzsche to explore the parallels in the authors' conceptions of paradox, the totality of life, and solitude among other themes in this exploration of the underlying philosophical similarities of these two great writers of the nineteenth century

4th Summer School in Immuno-Oncology, July 1st-3rd, 2021, Athens, Greece

The 4th Summer School in Immuno-Oncology was held from July 1st-July 3rd as a web meeting. Many eminent researchers and leading oncologists from Europe and the USA working on basic, translational and clinical cancer research participated, presented, and discussed the most recent advances in cancer immunology and immunotherapy. Besides sharing the newest information in the field of cancer immunology and immunotherapy, the meeting also focused on the actual translation of new knowledge acquired in the lab to the clinical setting; particular emphasis was given to the mode of action of novel therapeutic modalities and to biomarkers helpful for treatment decision-making, as well as to means that may improve cancer immunotherapeutic protocols used for the treatment of a variety of malignancies. The main topics presented by the speakers included: (1) mechanisms of tumor immune evasion and resistance; (2) host-tumor interactions and means to regulate antitumor immunity; (3) exploitation of new biomarkers and tumor or immune signatures able to potentially guide therapeutic interventions; (4) emerging therapeutic modalities for cancer treatment and specific immunotherapeutics for thoracic, genito-urinary, gastrointestinal, skin and breast cancers; and (5) innovative treatment options and alternatives to minimize the toxic adverse events of cancer immunotherapy. © 2021 The Author(s). Published by BRI